CALL US:022-6101 1700   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Laxmi Yadav, Mumbai February 25 , 2019
The Delhi High Court has issued notices to Union health and family welfare ministry and directorate general of health services of Delhi government on a public interest litigation (PIL) challenging the constitutional validity of Clinical Establishments (Central Government) Amendment Rules, 2018 as it has no mention of signatory authority in basic composite laboratories (small labs) thus violating the Supreme Court order and Article 21 of the Constitution.

The High Court also issued notice to National Accreditation Board for Testing and Calibration Laboratories (NABL) and Insurance Regulatory and Development Authority of India (IRDAI) in this regard.

On December 12, 2018 the government of National Capital Territory of Delhi issued a public notice seeking implementation of the new categorization brought about by the CEA Rules, 2018 to be implemented by all clinical establishments. The NABL has also incorporated the CEA Rules 2018 in its document NABL 112 which specified criteria for accreditation of medical laboratories. IRDAI has also issued a circular to insurance companies asking them to follow the said rules while clearing claims.

The PIL was filed by Dr Rohit Jain, founder member of Forum of Practicing Pathologists.

The petitioner stated that CEA Rules 2018 effective May 18, 2018 divided pathology laboratories into three categories namely, basic composite, medium and advanced, based on the kinds of tests which can be performed in such labs and the minimum standards for such categories of labs are prescribed under a schedule.

Under Column 3 of the Schedule titled as ‘human resource’ for ‘basic composite lab’ the qualification for an authorized signatory/technical head/specialist in a basic composite lab and the qualification of MBBS is prescribed as ‘desirable’ for such signatory of laboratory reports with a rider stating that ‘wherever interpretation of lab results or opinion there on are required, registered Bachelor of Medicine and Bachelor of Surgery (MBBS) medical practitioner is essential.'

Therefore, effectively no minimum standard has been prescribed for who can be the ‘authorized signatory’ of a report of laboratory test performed in a basic composite lab.

It is absurd that any ailing person would require a mere ‘technical report’ containing bare values and not have the same analyzed by a pathologist who would refer the patient to obtain requisite specialist doctor, further tests or immediate health aid after analyzing such values.

Under the garb of allowing non-medical persons to sign technical reports the impugned rules blatantly promote quackery, contravene the settled position of law, time and again reiterated and affirmed by several high courts, adopted by the Medical Council of India and further upheld by the apex court vide orders dated December 12, 2017 and July 10, 2018, he pointed.

Dr Jain stated that the amended rules further failed to prescribe relevant guidelines on crucial issues related to pathology laboratories viz. sample collection centres, sample transport, usage of scanned/electronic signatures by pathologists; number of laboratories a pathologist ought to be allowed to visit in a day; daily internal quality control and regulation of insurance claims.

The petitioner appealed to the high court to declare the Clinical Establishment Amendment Rules 2018 as unconstitutional and direct the health ministry to formulate relevant guidelines regarding aforesaid issues concerning pathology laboratories.

Meanwhile, he sought direction from the high court to the Union health ministry, Delhi government, NABL and IRDA to implement the order passed by the apex court during the pend ency of present proceedings.

The CEA Rules 2018 have been notified by the central government and as such is already adopted by 11 states and all Union territories (except Delhi) and is likely to be adopted by more states. Moreover, the issue of illegal pathology laboratories and other ancillary issues raised by way of the present petition concerns the entire nation and also requires central guidelines, he added.

Eighty per cent diagnostic laboratories in India are basic composite labs (defined in the CEA Rules 2018) amenable to the access of all of the Indian population, he pointed out.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
 
Website (required)
CommenT
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
That foods might provide therapeutic benefits is clearly not a new concept. ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)